Federal Regulations

After Congress passes a law, federal agencies write the detailed rules that make it real. Each rulemaking project gets a — and while a rule is proposed, anyone can comment on it.

13,034

rulemaking dockets

4,738

open for public comment

You can weigh in on these right now

Showing 30 of 13,034 dockets

Rulemaking

PHMSA

PHMSA-2026-1536

DOT requires public posting and comment chance for pipeline interpretation requests

1 docNo comments

Rulemaking

PHMSA

PHMSA-2026-1547

Transportation Department issues technical correction to offshore pipeline safety rules

1 docNo comments

Rulemaking

PHMSA

Open for Comments

PHMSA-2026-1552

DOT proposes to let more welders work on compressor station pipes by dropping testing exclusion

1 docNo comments

Comments due Jun 24, 2026

Rulemaking

PHMSA

PHMSA-2026-1544

DOT updates wording to clarify hazardous liquid and CO2 pipeline accident reporting

1 docNo comments

Rulemaking

PHMSA

Open for Comments

PHMSA-2026-1551

DOT proposes higher dollar thresholds for pipeline construction notices, adds annual inflation updates

2 docsNo comments

Comments due Jun 24, 2026

Rulemaking

PHMSA

PHMSA-2026-1545

DOT Fixes Wording Errors in Safety Rules for Low‑Stress Rural Hazardous Liquid Pipelines

1 docNo comments

Nonrulemaking

FDA

FDA-2026-N-3445

FDA Withdraws Approval for Three Generic Drug Applications Over Missing Annual Reports

1 docNo comments

Rulemaking

PHMSA

PHMSA-2026-1542

DOT removes outdated pipeline reporting clause to streamline safety rules

1 docNo comments

Rulemaking

PHMSA

PHMSA-2026-1546

DOT removes obsolete wording from hazardous liquid and CO2 pipeline reporting rules

1 docNo comments

Rulemaking

PHMSA

PHMSA-2026-1540

DOT Narrows and Clarifies Gas Pipeline Incident Reporting Rules

1 docNo comments

Nonrulemaking

FDA

FDA-1996-P-0056

Request That FDA Stop the Marketing of Cosequin (Dietary Supplement)

1 docNo comments

Rulemaking

PHMSA

Open for Comments

PHMSA-2026-1554

Pipeline rule would cap valve inspections at one year (max 15 months) for hazardous liquid and CO2 lines

2 docsNo comments

Comments due Jun 24, 2026

Nonrulemaking

FDA

FDA-2026-N-3334

FDA Publishes Annual Report on Drug Makers’ Follow‑Up Studies After Approval

1 docNo comments

Nonrulemaking

NARA

NARA-25-0011

NARA-2025-0034 Records Schedules

14 docs2 comments

Rulemaking

PHMSA

PHMSA-2026-1548

Transportation Department fixes outdated phone and fax numbers in pipeline safety rules

1 docNo comments

Rulemaking

PHMSA

PHMSA-2026-1539

DOT updates pipeline rule to allow electronic submission of interpretation and special permit requests

1 docNo comments

Nonrulemaking

FMCSA

FMCSA-2016-0235

In the Matter of Blue Waters Transport, Inc. – Petition for Administrative Review of a Proposed Conditional Safety Rating

4 docsNo comments

Rulemaking

PHMSA

PHMSA-2026-1538

DOT Allows Consent Agreements to Resolve All PHMSA Enforcement Cases, Including Fines

1 docNo comments

Nonrulemaking

FMCSA

FMCSA-2016-0233

In the Matter of Rac Pac, Inc. - Submission of Evidence

3 docsNo comments

Rulemaking

PHMSA

Open for Comments

PHMSA-2026-1549

DOT proposal trims redundant pipe testing rule for gas transmission safety

1 docNo comments

Comments due Jun 24, 2026

Nonrulemaking

FMCSA

FMCSA-2016-0232

In the Matter of King Konge Construction, LLC - Consent to Binding Arbitration or in the Alternative Motion for Final Order of Default

3 docsNo comments

Rulemaking

PHMSA

PHMSA-2026-1543

DOT tweaks wording for guided-wave ultrasound pipeline inspections, no new burdens

1 docNo comments

Nonrulemaking

FDA

FDA-2026-H-1618

DAB Civil Money Penalty; Rayah's Toys LLC d/b/a Vape & More; CLOSED 04/24/2026

1 docNo comments

Nonrulemaking

FMCSA

FMCSA-2016-0230

In the Matter of The Florida Movers of St Augustine Inc. - Motion for Default

7 docsNo comments

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-1831

Requests that the FDA take administrative action to improve the safety of discontinuing Cymbalta (duloxetine) and generic equivalents by requiring standardized tapering formulations, updated labeling, and patient access protections

3 docs3 comments

Nonrulemaking

FMCSA

FMCSA-2016-0229

In the Matter of B & C Transport, LLC - Regional Field Administrator's Consent to Binding Arbitration or Alternatively Motion for Final Order of Default

6 docsNo comments

Nonrulemaking

NHTSA

NHTSA-2025-0721

NHTSA Seeks OMB Renewal for Crash Data Collections; Public Comments Open Until April 23, 2026

2 docs29 comments

Nonrulemaking

FDA

FDA-2018-P-1846

Requests that the FDA immediately require the addition of boxed warnings, warning, preacautions, and highlights of prescribing information to the product label for all selective serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor products, including branded and generic formulations to warn of serious and severe risks.

62 docs35 comments

Nonrulemaking

FMCSA

FMCSA-2016-0228

In the Matter of Charnette L. Jones-Robinson - Submission of Evidence

4 docsNo comments

Nonrulemaking

FDA

Open for Comments

FDA-2025-P-3956

Request that the FDA add a boxed warning to SSRIs to inform patients, providers, and the public that use of these medications during pregnancy has been shown to be associated with increased rates of pregnancy complications and alteration of fetal brain development

179 docsNo comments